239 related articles for article (PubMed ID: 21048668)
1. A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms.
Pierce CG; Uppuluri P; Tummala S; Lopez-Ribot JL
J Vis Exp; 2010 Oct; (44):. PubMed ID: 21048668
[TBL] [Abstract][Full Text] [Related]
2. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
Ramage G; López-Ribot JL
Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
[TBL] [Abstract][Full Text] [Related]
3. Candida albicans biofilm chip (CaBChip) for high-throughput antifungal drug screening.
Srinivasan A; Lopez-Ribot JL; Ramasubramanian AK
J Vis Exp; 2012 Jul; (65):e3845. PubMed ID: 22847237
[TBL] [Abstract][Full Text] [Related]
4. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.
Ramage G; Vande Walle K; Wickes BL; López-Ribot JL
Antimicrob Agents Chemother; 2001 Sep; 45(9):2475-9. PubMed ID: 11502517
[TBL] [Abstract][Full Text] [Related]
5. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
6. Conditions for optimal Candida biofilm development in microtiter plates.
Krom BP; Cohen JB; McElhaney-Feser G; Busscher HJ; van der Mei HC; Cihlar RL
Methods Mol Biol; 2009; 499():55-62. PubMed ID: 19152039
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the antifungal effect of EDTA, a metal chelator agent, on Candida albicans biofilm.
Casalinuovo IA; Sorge R; Bonelli G; Di Francesco P
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1413-1420. PubMed ID: 28387883
[TBL] [Abstract][Full Text] [Related]
8. Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms.
Martins M; Henriques M; Lopez-Ribot JL; Oliveira R
Mycoses; 2012 Jan; 55(1):80-5. PubMed ID: 21668524
[TBL] [Abstract][Full Text] [Related]
9. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.
Seneviratne CJ; Jin LJ; Samaranayake YH; Samaranayake LP
Antimicrob Agents Chemother; 2008 Sep; 52(9):3259-66. PubMed ID: 18625775
[TBL] [Abstract][Full Text] [Related]
10. Microplate Alamar blue assay for susceptibility testing of Candida albicans biofilms.
Repp KK; Menor SA; Pettit RK
Med Mycol; 2007 Nov; 45(7):603-7. PubMed ID: 17885957
[TBL] [Abstract][Full Text] [Related]
11. A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms.
DiDone L; Oga D; Krysan DJ
Yeast; 2011 Aug; 28(8):561-8. PubMed ID: 21674619
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of antifungal combinations against planktonic and sessile cells of Candida albicans isolated from medical devices in an intensive care department.
Touil HFZ; Boucherit-Otmani Z; Boucherit K
J Mycol Med; 2018 Sep; 28(3):414-418. PubMed ID: 30032993
[TBL] [Abstract][Full Text] [Related]
13. Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms.
Nweze EI; Ghannoum A; Chandra J; Ghannoum MA; Mukherjee PK
J Antimicrob Chemother; 2012 Jan; 67(1):149-53. PubMed ID: 21990050
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.
Prażyńska M; Bogiel T; Gospodarek-Komkowska E
Folia Microbiol (Praha); 2018 Mar; 63(2):209-216. PubMed ID: 28983822
[TBL] [Abstract][Full Text] [Related]
15. Biofilm of Candida albicans: formation, regulation and resistance.
Pereira R; Dos Santos Fontenelle RO; de Brito EHS; de Morais SM
J Appl Microbiol; 2021 Jul; 131(1):11-22. PubMed ID: 33249681
[TBL] [Abstract][Full Text] [Related]
16. A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms.
Chandley P; Subba P; Rohatgi S
J Vis Exp; 2022 Sep; (187):. PubMed ID: 36190282
[TBL] [Abstract][Full Text] [Related]
17. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
[TBL] [Abstract][Full Text] [Related]
18. A 384-Well Microtiter Plate Model for Candida Biofilm Formation and Its Application to High-Throughput Screening.
Ajetunmobi OH; Wall G; Bonifacio BV; Montelongo-Jauregui D; Lopez-Ribot JL
Methods Mol Biol; 2023; 2658():53-64. PubMed ID: 37024695
[TBL] [Abstract][Full Text] [Related]
19. Antifungal susceptibility of Candida albicans in biofilms.
Tobudic S; Kratzer C; Lassnigg A; Presterl E
Mycoses; 2012 May; 55(3):199-204. PubMed ID: 21793943
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals.
Watamoto T; Samaranayake LP; Egusa H; Yatani H; Seneviratne CJ
J Med Microbiol; 2011 Sep; 60(Pt 9):1241-1247. PubMed ID: 21474609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
